- About LES
- Join LES
- Professional Groups
|Board of Directors' Biographies|
Jim is the President and CEO at Innovate IP, Inc and was most recently the Assistant Vice President for Economic Development and the Executive Director of the Commercialization and Venture Center at The University of Oklahoma. He teaches Entrepreneurship in the Price College of Business and manages two technology investment funds for OU. Jim is also the Chairman of the Oklahoma Venture Forum.
Prior to joining the University, Jim spent over 15 years as a Venture Capitalist investing in start-ups and university spin-outs. He has led new company formations, follow-ons, strategic partnerships and exits as well as secondary investments in partnership funds. Most recently, Jim led an Atlanta-based IP search firm, IP2Biz, to a successful turnaround by implementing a new business strategy, company reorganization and financial recapitalization.
Jim began his career with BFGoodrich Aerospace managing operational and customer support resources for commercial airlines in Europe, Africa and the Middle East. He is an Eagle Scout, Scoutmaster, recipient of the Charles L. Sommers Triple Crown Award and an avid fly fisherman. He earned his MBA from Duke University and holds a BA in French and Economics from Sewanee: The University of the South.
Ann received her B.Ch.E. degree from Villanova University and J.D. from the Catholic University of America, and is a Certified Licensing Professional (CLP).
Before joining Ericsson, Evelyn was a patent litigator and prosecutor at Sidley Austin LLP, representing both national and international clients. She also clerked for the Honorable David Folsom in the United States District Court for the Eastern District of Texas.
Evelyn has an Electrical Engineering degree and a law degree from The University of Texas at Austin. Prior to attending law school, Evelyn worked as a registered patent agent for several years, prosecuting patents in a wide-range of technologies ranging from telecommunications to biomedical instrumentation.
Evelyn is currently serving as a member of the LES Standards Board.
Mr. DiBernardo is currently Chair of the 2019 LES Annual Meeting and Past Chair of the High Technology Sector. He received his law degree from Boston University School of Law, his J.D. from Syracuse University College of Law, and his B.S. in Electrical Engineering from Bucknell University.
Gary has served on the LES Board of Directors since 2012 in multiple roles including Senior Vice President Meetings, Education and Strategic Alliances. Previously, he was the Trustee for Education: Webinars and has served as the Trustee for Sponsorship. Gary also served as President of the LES Foundation from 2014-2016 and Secretary from 2013-2014. Additionally, he was the Co-Chair of the 2012 Annual Meeting and one of the leaders responsible for the strong programming planned for the 2012 Annual Meeting. An active member of the High-Tech Sector (HTS) for over ten years, Gary has served as Chair of the HTS Standards Committee, a facilitator at roundtable sessions and a frequent member of Annual Meeting planning committees. Currently Gary holds the position of President-elect and Chair-elect of the LES Board of Trustees.
Gary is a shareholder with the law firm of Banner Witcoff. He has practiced intellectual property (IP) law for over two decades. He has a broad base of experience in IP including involvement in all phases of the preparation and prosecution of patent applications before the USPTO, participating in patent infringement litigation in U.S. District Courts and post-issuance proceedings including preparation of IPRs. Also, Gary advises clients on IP issues including portfolio management, due diligence, validity and right-to-use opinions and licensing matters. In recent years, Gary has spoken on topics related to the America Invents Act (AIA).
Gary is a Certified Licensing Professional (CLP) and earned a B.S. in Computer and Systems Engineering from Rensselaer Polytechnic Institute and a J.D. from the George Washington University Law School.
Gillian M. Fenton, Esq., CLP has been a member of LES (USA & Canada) since 1992. She has served in a variety of roles, including as member of the LES Insights Editorial Board and later Chair of the Editorial Board; as a volunteer mentor for the LES Foundation International Business Plan Competition, and as Director for Communications and Publications. Gillian is presently a member of the LES Board Executive Committee and serves on a number of other LES Board committees.
Gillian is presently Senior Counsel at GSK Vaccines, where she is the sole North American attorney for significant vaccines pipeline business development transactions (acquisitions, in-licenses, collaborations, out-licenses, and asset divestments). Gillian’s practice also includes a wide variety of collaborations and R&D funding agreements with U.S. Government entities (NIH/NIAID, BARDA and DARPA). Prior to joining GSK, Gillian was VP, Associate General Counsel & Chief Intellectual Property Counsel at Emergent BioSolutions Inc., where she founded the IP department and oversaw all IP activities in support of Emergent's IPO and subsequent growth through M&A. Prior to joining EBS, while in-house patent counsel at Biogen Inc., Gillian led all IP activities in support of market launch of a new biotherapeutic product and secured a favorable outcome in a precedential patent interference proceeding. She also has over 12 years’ experience in private practice at Boston-based law firms.
Education: J.D. cum laude, Suffolk University Law School; B.Sc. Biochemistry, Trinity College. Admissions: MA, MD, DC. Registered U.S. Patent Attorney.
Currently, as Global Head of BD&L, Lalit leads a team responsible for executing BD&L transactions and strategy for VETOQUINOL, one of the globally leading pharmaceutical companies focused on animal health. Prior to joining VETOQUINOL, Lalit led and founded a management consulting advising clients ranging from governments to startup on BD&L transactions. Lalit has served in many BD&L capacities and across many segments of the life sciences industry. He started his career in human medical diagnostics, then to life sciences research and on to leading BD&L for Novartis AH, then to his current role.
Lalit has been a member of the Licensing Executives Society for more than 15 years and currently serves as Chair of the Life Sciences Sector. Over the last decade or so, Lalit has remained very active with life sciences serving as a mentor, a judge to the business plan competition, and co-chair of many sub-committees in the Life Sciences Sector. He earned an MBA from Rice University and MS in Biology (Molecular) from Texas A&M.
Bob has been active in LES (USA & Canada) since 1998 having served in the following roles: Chair of the Aerospace and Transportation Subcommittee of the High Tech Sector (HTS) 2006-2007; Co-Chair and co-author of the HTS Royalty Rate and Deal Terms Surveys for 2011, 2014 and 2017; Secretary of the HTS 2011-2012; Vice-Chair of the HTS 2012-2013; Chair of the HTS 2013-2014; Workshop Chair for the 2012 HTS Winter Meeting; Program Chair for the 2012 LES Annual Meeting, Program Chair for the 2013 LES Annual Meeting, and LES Trustee for Content Creation, Capture and Delivery on the LES Board of Trustees 2012-2014. Currently Bob holds the position of President and Chair of the LES Board of Trustees. In addition, Bob has organized and presented workshops and mini-plenary sessions on a variety of IP topics, and is a frequent LES faculty member.
Bob is the President of Held Intellectual Property, LLC, and recently worked for TeleCommunication Systems, Inc. (TCS) in Annapolis, Maryland as the Vice President, Intellectual Asset Management, responsible for the strategic management and monetization of TCS’s IP portfolio. All assets of TCS were acquired in February 2016. Immediately prior to joining TCS, Bob worked for Northrop Grumman Corporation, Electronic Systems Sector from 2003-2011 as the Director of the Intellectual Property & Strategic Technology Agreements business unit; and from 1998-2003 he worked at the IP firm British Technology Group (BTG) International.
Bob has been a Certified Licensing Professional (CLP) since 2008 and was named to the “IAM Strategy 300 - The World’s Leading IP Strategists” each year since 2015. Bob received his Bachelor of Science in Electrical Engineering degree from Villanova University and his MBA from Drexel University’s LeBow College of Business.
Rachel has been a member of LES since 2002 and has served as the Vice President Public Policy and Standards. She has been an active member of LES participating on the Public Policy Committee for the last several years. She currently serves as a Trustee at Large.
Rachel is Senior Assistant General Counsel for Purdue Pharma L.P. in Stamford, Connecticut. She manages patent litigation, primarily Hatch-Waxman cases, and settlements of patent litigation. She also is involved with IP licensing. After law school, Rachel went directly in house to Purdue. At the beginning of her career, her work was focused on licensing agreements to support Purdue’s discovery research and other research groups, including licensing agreements with universities.
In 1999, Rachel received her B.S. in Chemistry with a minor in Management (concentrating on Entrepreneurship) from Rensselaer Polytechnic Institute. She attended Chicago-Kent College of Law in its Honors Scholars program and received a J.D. with a certificate in Intellectual Property in 2002. She is admitted to practice in the states of Connecticut and New York and the USPTO.
Louise Levien, Ph.D., CLP Louise has recently retired from a career that included a diverse series of assignments at Exxon and ExxonMobil in Upstream Research. During her career she has performed research in Petrophysics, Geologic Modeling, and Visualization, supervised diverse research programs and held several assignments in Planning and Analysis. After working with IP from the scientific side of ExxonMobil for many years, Louise joined the ExxonMobil Upstream Research Company’s Commercial, Intellectual Property and Licensing group in 2007. She was responsible for IP processes, the intellectual property aspects of agreements, and licensing transactions impacting ExxonMobil's upstream business. She holds a ScB degree in Geological Sciences from Brown University and MS and PhD degrees in Geochemistry from Stony Brook University. She is a Certified Licensing Professional and co-inventor on two patents.
Annemarie Meike is a Business Development Executive having responsibility for commercialization of technologies and management of intellectual property portfolios for energy, environment, sensors, wireless technologies and nanomaterials at LLNL since 2000. Named by Intellectual Assets Magazine as one of the World’s Leading IP Strategists, she negotiates business partnerships, and coaches and facilitates successful start-up companies, several of which have received prestigious R&D 100 awards. She also has engaged in business development and technical audits in the former Soviet Union, on behalf of the U.S. Department of Energy and the U.S. State Department. Annemarie has been recognized for excellence in technology licensing and the development of working partnerships by Santa Clara University, LLNL and the Federal Laboratory Consortium (FLC). Annemarie joined LLNL in 1989 to design, build and manage a multi-disciplinary scientific program predicting the ultra-long-term degradation of materials, which she directed for 10 years. She was co-founder and organizing chair of the International Alloy Conferences, and sits on an Advisory Board of a National Science Foundation International Materials Institute. Annemarie holds a Ph.D. in Geology with an emphasis in Materials from University of California, Berkeley, and a J.D. from Santa Clara University. Annemarie has traveled widely, including research as a Senior Fulbright Fellow at Australian National University and teaching secondary school in Sierra Leone, West Africa. She has owned and directed two start-up companies, one in the U.S. and one in Australia. She is a member of several technical professional societies, and has held key leadership and founding roles in the Licensing Executives Society (LES) USA & Canada and the LES Foundation. She previously served as Director of the LES Foundation International Graduate Student Business Plan Competition.
Lesley Millar-Nicholson, has been the Director of MIT Technology Licensing Office (TLO) since July 2016. She leads a team of professional staff managing the intellectual assets and technology transfer process for MIT's inventions. Located in Kendall Square the TLO is responsible for engagement with faculty, staff and students and for the efficient and effective transfer of IP into the market place to ensure impact in society. Working with MIT startup companies, VC's and corporate partners the team manage over 800 inventions a year from the MIT and Lincoln Lab campuses. The MIT portfolio includes over 2500 issued US patents, 1,000 active licenses with over 400 yielding revenue. The TLO is an integral part of the MIT innovation ecosystem working closely with the Industrial Liaison Program, Office of Sponsored Programs, the Deshpande Center, Sandbox Innovation Fund Program, Venture Mentoring Service, Martin Trust Entrepreneurship Center, MIT Innovation Initiative and many other programs and centers established to harness the amazing innovations from MIT faculty, students and staff. Prior to arriving in Cambridge Ms. Millar-Nicholson had served for ten years as Director of the Office of Technology Management (OTM) at the University of Illinois, Urbana/Champaign. Ms. Millar-Nicholson is the Immediate Past President of the Board of Governors of Certified Licensing Professionals Inc, (CLP Inc.), an active member of AUTM and the Licensing Executive Society. A native of Scotland, Ms. Millar-Nicholson has a B.Ed., M.Ed, MBA and is a Certified Licensing Professional.
Mike Pellegrino currently serves as Treasurer on the LES Board of Directors and is the Founder and President of Pellegrino & Associates, LLC (P&A), a boutique intellectual property (IP) valuation firm. He has significant experience valuing patents and other forms of intellectual property, establishing royalty rates, and evaluating businesses. His company engagements number more than 400 for more than 200 clients, ranging from Fortune 100 companies like IBM, GE, State Farm, Liberty Mutual, American Express, and Lockheed Martin to startups. Judges, attorneys, and government entities such as the IRS and the SEC have widely accepted his work product. Courts at the state and federal level, tax jurisdictions, and arbitration panels have accepted Mike’s work for issues including bankruptcy valuations, estate tax valuations, copyright infringement claims, trade secret misappropriation claims, patent infringement claims, breach of contract claims and others. One North Carolina court stated that Mike’s work is “clearly in the mainstream of IP valuation methodologies” and that his qualifications were “outstanding.”
Mike’s experience positions him as a market leader in intangible asset valuation. He is the author of first and second editions of BVR’s Guide to Intellectual Property Valuation, selling more than 700 books to a variety of customers including attorneys, tech transfer officers, business valuation firms, competing IP valuation firms, and more. In addition, his finance- and software-related articles appear in internationally and nationally recognized outlets, such as IAM Magazine, CFO Magazine, MSNBC.com, FoxNews.com, and others. Mike has had the pleasure of teaching thousands of people about valuations. Various venues around the globe, including law firms, universities, accounting firms, appraisal firms, valuation firms, state bar associations, and other organizations, frequently request his expertise at speaking engagements regarding intangible asset valuations and the tax effects of embedded application software and intellectual property.
His educational background includes a Bachelor’s degree in computer science from Indiana Institute of Technology and a Master’s degree in business administration from Ball State University. He also completed additional accounting coursework sufficient to fulfill the academic requirements for an undergraduate accounting degree. In addition, he completed both the 15-hour and 7-hour update USPAP training programs. He remains current with all USPAP training. Further training involves numerous ICLEF and NBI seminars on a variety of issues.
Her IP transactions practice includes: technology licensing and other commercialization agreements; multiparty collaboration and joint venture agreements; product manufacturing, supply, and distribution agreements; and software development/support and service agreements, among others.
She previously was an Associate Director for Technology Development at the Univ. of Texas Medical Branch (UTMB). In that role, she developed commercialization strategies for various technologies, and led numerous successful technology commercialization deals, including helping to structure six life sciences start-up companies. She has been recognized by Texas Super Lawyers® as a Rising Star in Intellectual Property in 2018 and 2019. In addition to her significant technology transfer practice, Karthika also has experience in the prosecution of patents and trademarks for large corporate entities, research institutions and independent inventors.
Ms. Perumal is a Certified Licensing Professional (CLP) and received her J.D. from University of Houston Law Center and her Ph.D in Pharmacology from Baylor College of Medicine.
Kevin R. Spivak currently serves as Secretary on the LES Board of Directors and is a member of the intellectual property law firm of Vierra Magen Marcus LLP. Mr. Spivak's experience includes managing and securing intellectual property rights in a wide variety of technologies for domestic and global corporations.
Mr. Spivak represents major corporate clients in counseling, prosecuting and preparing both foreign and domestic patent applications, including filings via the Patent Cooperation Treaty. Mr. Spivak also advises in support of patent litigation and licensing negotiations, including cases before district and federal courts and the International Trade Commission (ITC), and prepares infringement, validity, freedom-to-operate and patentability opinions. He also conducts due diligence studies in all aspects of intellectual property.
The technologies involved in Mr. Spivak's daily practice include networks, telecommunications, mobile devices, VoIP, Internet telephony, power generation, semiconductors, optics, display technology, DVD technology and standards, gaming, automotive, computer hardware and software, and business methods.
Before completing law school, Mr. Spivak was a Patent Examiner in the USPTO, where he examined patent applications in computer-related technologies. Mr. Spivak received a B.S. in Computer Engineering from The George Washington University and a J.D. from The American University, Washington College of Law.
Specialties: Patent prosecution, including drafting and prosecuting applications before the USPTO; Due diligence; Data Mining and Landscaping; Opinions; Portfolio Management, Computer, Internet, Telecommunications and Business Method patents.
Karen has served on the LES Education Committee and as the LES Toronto Chapter Chair of the LES (U.S.A. and Canada). Ms. Temple received her Ph.D., Materials Chemistry from the University of Toronto.
Eric Victory is Vice President & Head for cardiovascular, renal, metabolic, and infectious diseases within the Partnering & Strategy group at MedImmune, the biologics R&D unit for AstraZeneca, located in Gaithersburg, Maryland. In this role he is responsible for leading the company's early (pre-proof of concept) biologic externalization activities in two of our therapeutic areas, and for working with the CV/Renal/Metabolism and Microbial Sciences (Infectious Disease) Innovative Medicines Leadership Teams to drive and define the respective therapeutic area strategies within MedImmune. In this role, Eric has successfully closed the acquisitions of Spirogen and Amplimmune, brought on Sanofi Pasteur as a partner in developing MedImmune's MEDI8897 RSV antibody, and led key agreements with Inovio Pharmaceuticals, Omnis Pharmaceuticals, the Danish Diabetes Academy, the Joslin Diabetes Center, Shionogi, Advaxis, Immunocore, ADC Therapeutics, and NGM Biopharmaceuticals, all signed since the summer of 2013.
Prior to taking the Partnering and Strategy role in 2013, Eric was part of the MedImmune Corporate Development and Ventures team since 2011, with responsibility for business development and licensing transactions with university, academic, and non-profit institutions and in the cardiovascular, gastrointestinal, and metabolic disease therapeutic area, as well as oversight of MedImmune's pandemic influenza contracts with the United States Government. Eric joined MedImmune in 2002 as a Product Manager in MedImmune's Marketing Department and worked on Synagis (palivizumab), CytoGam (CMV-IVIG) and RespiGam (RSV-IVIG). In 2006 Eric joined MedImmune's Business Development Department where he has worked on licensing transactions across a range of therapeutic areas, including completing licenses with Trellis Biosciences, Immune Design Corporation, and Amgen, as well as out-licenses of MedImmune's reverse genetics intellectual property estates. Eric holds undergraduate degrees in physics and political sciences from Stanford University, and an MBA from Northwestern University's Kellogg School of Management.
Scott is Vice President of Licensing and Technology Ventures at General Electric. Previously, he served as Director, Licensing at InterDigital, a leading mobile technology R&D company. Prior to joining InterDigital, Scott served as Director with Stout Risius Ross, Inc. (formerly Invotex) where he led the transaction services practice area. He was responsible for managing the sale and licensing of clients' intellectual property assets as well as providing consulting services related to both litigation and the valuation of intellectual property and technology businesses. Scott has more than 20 years of experience in licensing and business development as well as in consulting to technology businesses.
He also served as Vice President in the Strategic Business Development and Technology Commercialization business units of BTG plc, a British technology development and licensing company. Earlier in his career, Scott served as Director of Sales and Marketing for a start-up manufacturer of industrial computers and plant floor workstations where he was responsible for building a national distribution network and leading the company through a period of dynamic sales growth.
As a 18+ year member of LES, Scott has served on the LES Board since 2016, has served in the role of Director of Meetings, was previously also the Chair of the Philadelphia Chapter, and was the 2015 New York Annual Meeting Chair.
Scott received his BS in Mechanical Engineering from the University of Pittsburgh and his MBA from Temple University. He is also a Certified Licensing Professional (CLP) and a Certified Valuation Analyst. Scott is an author and frequent speaker on licensing and IP valuation topics.